What You Should Know About Xarelto vs. Warfarin

Approved by the US Food and Drug Administration (FDA) in 2011, Xarelto has quickly become “the #1 prescribed novel oral anticoagulant in the US”.  With financial analysts calculating that Bayer and Johnson & Johnson could see $3.7 billion in sales for Xarelto by 2018, Xarelto has surely begin to overtake its predecessor Warfarin.

As one of the new generation blood thinners prescribed to patients who suffer from conditions such as deep vein thrombosis (DVT) and atrial fibrillation (AF), Xarelto has been marketed as the superior option to previous gold standard Warfarin, as it requires less medical checkups.

But it is that same lack of medical oversight that has come under heavy scrutiny because of the anticoagulant’s side effects, which have included serious uncontrollable internal bleeding, hospitalization, emergency surgery, and even death.

At Hotze Runkle, we believe that informing our clients is one of our most important responsibilities, and one of the best measures to inhibit major corporations from taking advantage and damaging the lives of innocent people.

Consider the following information about Xarelto vs. Warfarin if you have recently been prescribed the medication.

About Warfarin

Warfarin was the gold standard blood-thinning medication for many years. Initially approved by the FDA during the 1950’s, Warfarin was prescribed to patients who suffered from a host of ailments including those suffering from potential blood clots, to prevent strokes in individuals with atrial fibrillation, as well as for patients who suffered from DVT or PE.

With decades of positive use to its name, Warfarin had proven itself to be a highly reliable medication for various illnesses.

Xarelto recently emerged as an alternative to Warfarin and based much of its value on the notion that patients would not have to undergo constant medical monitoring.  Because Warfarin required patients to have monthly blood tests performed, as well as dietary restrictions, physician’s began to prescribe Xarelto consistently.

But the differences between the two are noteworthy for patients to know.

What are the difference between Warfarin and Xarelto?

There are some major variations between the medications that should be considered for patients on Xarelto including:

  • They affect the body differently. It is important to note the meaningful difference between Warfarin as a blood thinner and Xarelto as an anticoagulant medication. Warfarin makes the blood less likely to clot by inhibiting the use of vitamin K within the body, which is used to form blood clots. Xarelto, on the other hand, completely disables the body’s ability to form any clots whatsoever. Meaning that if a patient on Xarelto starts bleeding (hemorrhaging) there is very little a physician can do to stop it.
  • Warfarin has an antidote. Xarelto does NOT. While most medications carry some form of potentially hazardous side effect, Xarelto’s lack of an antidote can be deadly. In patients who have taken too much Warfarin are suffering the side effects, these can be countered by injecting the patient with a dose of vitamin K.

Xarelto, unfortunately, does not currently have any FDA-approved antidotes. This can lead to significant bleeding events that can take hours to stop, potentially leading to deadly situations.

  • New anticoagulant medications like Xarelto may not be safe for certain medical conditions. If you have been prescribed Warfarin for some time and have not experienced any bleeding problems or issues that required immediate medical attention, then it is probably safer to remain on the traditional medication. This is especially true if you have other medical conditions to consider such as kidney failure or mechanical heart valves. Newer anticoagulants may not be safe for you.
  • Xarelto may carry up to twice the risk of internal bleeding as warfarin. Despite Xarelto manufacturer Bayer and Johnson & Johnson constantly claiming the conveniences of their anticoagulant medication, research conducted by John Hopkins University and published in the British Medical Journal (BMJ) suggest that the new generation blood thinners may increase the risk of gastrointestinal bleeding in patients by twice as much as warfarin.

If you or a loved one has suffered through the painful and serious side effects of Xarelto, do not hesitate to contact the law offices of Hotze Runkle today at (877) 919-0830.

Utilizing Xarelto as a treatment for various health conditions can jeopardize a patient’s internal organs, life, and future wellbeing. Research has continually confirmed that the anticoagulant often produces more harm than it does benefits.

Our reliable national litigation team at Hotze Runkle are here to guide and support individuals and families who have been injured by Xarelto.

Your situation may mean you are entitled to compensation for your pain and suffering.
Contact us today to find out how we can help.